Chronic T-Cell Leukemia (CTCL) Latest Advances

Cladribine and venetoclax combined with alemtuzumab in patients with relapsed/refractory T-cell prolymphocytic leukemia.

Journal: Leukemia & lymphoma

Published: October 22, 2025

Epidemiology and survival of patients with T-cell prolymphocytic leukemia.

Journal: Blood cancer journal

Published: September 07, 2025

Phase 1B pilot study of itacitinib with alemtuzumab in patients with T-cell prolymphocytic leukemia.

Journal: Blood neoplasia

Published: June 18, 2025

Asymptomatic T prolymphocytic leukemia: case report and literature review.

Journal: Einstein (Sao Paulo, Brazil)

Published: May 24, 2025

Composite mantle cell lymphoma and T-cell prolymphocytic leukemia: a case report.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: April 29, 2025

Pseudohyperkalemia in a Patient with Leukemia: A Diagnostic Pitfall in Emergency Medicine.

Journal: The Journal of emergency medicine

Published: February 27, 2025

Altered immune cell profiles in blood of mature/peripheral T-cell leukemia/lymphoma patients: an EuroFlow study.

Journal: Frontiers in immunology

Published: January 15, 2025

Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia.

Journal: Leukemia

Published: January 10, 2025

Correction: Computational gene expression analysis reveals distinct molecular subgroups of T-cell prolymphocytic leukemia.

Journal: PloS one

Published: December 05, 2024

Proteasome Inhibitors Induce Apoptosis in Ex Vivo Cells of T-Cell Prolymphocytic Leukemia.

Journal: International journal of molecular sciences

Published: November 12, 2024

T-Cell Prolymphocytic Leukemia With PDGFRB Rearrangement in the Setting of Neurofibromatosis Type 1.

Journal: International journal of laboratory hematology

Published: November 08, 2024

Discovery of molecularly-informed therapeutic strategies for mature T-cell leukemias and lymphomas.

Journal: Blood advances

Published: October 23, 2024